Gradually glycosylated protein C mutants (Arg178Gln and Cys331Arg) are degraded by proteasome after mannose trimming

Summary

Proteins that fail to attain their correct three-dimensional structure are retained in the endoplasmic reticulum (ER) and eventually degraded within the cells. We investigated the degradation of mutant proteins, using naturally occurring protein C (PC) mutants (Arg178Gln and Cys331Arg) which lead to congenital deficiencies. Chinese hamster ovary (CHO) cells were transfected with normal or mutant expression vectors. The introduction of mutation at Asn329 of an unusual sequence Asn-X-Cys for N-linked glycosylation revealed that the mutation at Cys331, which may preclude a formation of disulfide bond with Cys345, resulted in no addition of N-linked oligosaccharides at Asn329. PC mutants with 4 glycosylation sites were gradually glycosylated in the ER, and the fourth glycosylation site is less accessible for glycosylation as reported for PC in plasma.The half lives of PC178 and PC331 mutants were about 5 and 4 h, respectively. PC mutants were degraded, but the degradation was inhibited by inhibitors for proteasome. Mannose trimming of N-linked oligosaccharides after glucose removal targeted PC mutants for degradation by proteasomes. And also the inhibition of glucose trimming immediately led to mannose trimming, resulting in the accelerated degradation of PC mutants. These degradations were inhibited by mannosidase I inhibitor, kifunensine. These results indicate that the initiation of mannose trimming by mannosidase I leads to the proteasomemediated degradation of glucose-trimmed or untrimmed PC mutants.

Keywords

Protein C - mutation - degradation - proteasome - N-linked oligosaccharides

• References

• 1 Dahlbäck B. Progress in the understanding of the protein C anticoagulant pathway. Int J Hematol 2004; 79: 109-16.
• 2 Reitsma PH. Protein C deficiency: from gene defects to disease. Thromb Haemost 1997; 78: 344-50.
• 3 Kisiel W. Human plasma protein C: isolation, characterization, and mechanism of activation by α-thrombin. J Clin Invest 1979; 64: 761-9.
• 4 Foster D, Davie EW. Characterization of a cDNA coding for human protein C. Proc Natl Acad Sci USA 1984; 81: 4766-70.
• 5 Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985; 54: 631-64.
• 6 Parodi AJ, Mendelzon DH, Lederkremer GZ. Transient glucosylation of proteinbound Man₉GlcNAc₂, Man₈GlcNAc₂, and Man₇GlcNAc₂ in calf thyroid cells A possible recognition signal in the processing of glycoproteins. J Biol Chem 1983; 258: 8260-5.
• 7 Klausner RD, Sitia R. Protein degradation in the endoplasmic reticulum. Cell 1990; 62: 611-4.
• 8 Kopito RR. ER quality control: the cytoplasmic connection. Cell 1997; 88: 427-30.
• 9 Chung DH, Ohashi K, Watanabe M. et al. Mannose trimming targets mutant α2-plasmin inhibitor for degradation by the proteasome. J Biol Chem 2000; 275: 4981-7.
• 10 Manabe S, Matsuda M. Homozygous protein C deficiency combined with heterozygous dysplasminogenemia found in a 21-year-old thrombophilic male. Thromb Res 1985; 39: 333-41.
• 11 Sugahara Y, Miura O, Hirosawa S. et al. Compound heterozygous protein C deficiency caused by two mutations, Arg-178 to Gln and Cys-331 to Arg, leading to impaired secretion of mutant protein C. Thromb Haemost 1994; 72: 814-8.
• 12 Horton RM, Hunt HD, Ho SN. et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989; 77: 61-8.
• 13 Miura O, Hirosawa S, Kato A. et al. Molecular basis for congenital deficiency of α₂-plasmin inhibitor A frameshift mutation leading to elongation of the deduced amino acid sequence. J Clin Invest 1989; 83: 1598-604.
• 14 Stenflo J, Fernlund P. Amino acid sequence of the heavy chain of bovine protein C. J Biol Chem 1982; 257: 12180-90.
• 15 Titani K, Kumar S, Takio K. et al. Amino acid sequence of human von Willebrand factor. Biochemistry 1986; 25: 3171-84.
• 16 Miletich JP, Broze Jr GJ. β protein C is not glycosylated at asparagine 329 The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites. J Biol Chem 1990; 265: 11397-404.
• 17 Grinnell BW, Walls JD, Gerlitz B. Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J Biol Chem 1991; 266: 9778-85.
• 18 Simioni P, Kalafatis M, Millar DS. et al. Compound heterozygous protein C deficiency resulting in the presence of only the β???????????form of protein C in plasma. Blood 1996; 88: 2101-8.
• 19 Perera L, Foley C, Darden TA. et al. Modeling zymogen protein C. Biophys J 2000; 79: 2925-43.
• 20 Tokunaga F, Brostrom C, Koide T. et al. Endoplasmic reticulum (ER)-associated degradation of misfolded N-linked glycoproteins is suppressed upon inhibition of ER mannosidase I. J Biol Chem 2000; 275: 40757-64.
• 21 Hosokawa N, Wada I, Hasegawa K. et al. A novel ER α-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep 2001; 02: 415-22.
• 22 Hosokawa N, Tremblay LO, You Z. et al. Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong α₁-antitrypsin by human ER mannosidase I. J Biol Chem 2003; 278: 26287-94.